Ronald M. Burch
Keine laufenden Positionen mehr
Profil
Dr. Ronald M.
Burch is Chief Medical Officer at Naurex, Inc.
Dr. Burch was previously employed as Chief Executive Officer by AlgoRx Pharmaceuticals, Inc., Chairman & Chief Executive Officer by Biowave Corp., an Advisory Board Member by Carrot Capital LLC, an Advisor by Connecticut Innovations, Inc., and Chief Medical Officer by Pacira Pharmaceuticals, Inc.
He received his undergraduate degree from the College of Charleston and a doctorate degree from Medical University of South Carolina.
Ehemalige bekannte Positionen von Ronald M. Burch
| Unternehmen | Position | Ende |
|---|---|---|
Connecticut Innovations, Inc.
 Connecticut Innovations, Inc. Investment ManagersFinance Connecticut Innovations, Inc (CI) is venture capital firm founded in 1989. The firm is headquartered in Rocky Hill, Connecticut. | Direktor/Vorstandsmitglied | 31.05.2007 |
Naurex, Inc.
 Naurex, Inc. Pharmaceuticals: MajorHealth Technology Naurex, Inc. operates as a clinical-stage company, which develops therapies. The firm offers therapies for depression and other disorders in the central nervous system based on a mechanism of action for modulating the NMDA receptor (NMDAR). It offers a line of chemical drug classes, such as glycine-site functional partial agonists, which modulate the receptor in a different way than existing NMDAR agents. The firm provides GLYX-13, an NRX-1050 small molecule series and additional compounds for treatment-resistant depression. The company was founded by Joseph R. Moskal in 2006 and is headquartered in Evanston, IL. | Technik-/Wissenschafts-/F&E-Leiter | - |
| PACIRA BIOSCIENCES, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Biowave Corp.
 Biowave Corp. Medical SpecialtiesHealth Technology Biowave Corp. develops neuromodulation pain therapy medical devices. It offers products that include BiowavePRO and Homewave. The firm's products are first line therapies for treating chronic, acute or postoperative musculoskeletal pain. Its products include biowavePENS, biowave PRO, biowavePRO leadwire cable, noninvasive electrodes, and percutaneous electrodes. The company was founded in 2000 by Bradford E. Siff and is headquartered in Norwalk, CT. | Vorstandsvorsitzender | - |
Embark Healthcare
 Embark Healthcare Investment ManagersFinance Embark Healthcare (Embark Healthcare) is a ventures capital firm founded in 2001 by David M Geliebter. The firm is headquartered in New York. | Berater | - |
Ausbildung von Ronald M. Burch
| Medical University of South Carolina | Doctorate Degree |
| College of Charleston | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PACIRA BIOSCIENCES, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Connecticut Innovations, Inc.
Connecticut Innovations, Inc. Investment ManagersFinance Connecticut Innovations, Inc (CI) is venture capital firm founded in 1989. The firm is headquartered in Rocky Hill, Connecticut. | Finance |
Biowave Corp.
Biowave Corp. Medical SpecialtiesHealth Technology Biowave Corp. develops neuromodulation pain therapy medical devices. It offers products that include BiowavePRO and Homewave. The firm's products are first line therapies for treating chronic, acute or postoperative musculoskeletal pain. Its products include biowavePENS, biowave PRO, biowavePRO leadwire cable, noninvasive electrodes, and percutaneous electrodes. The company was founded in 2000 by Bradford E. Siff and is headquartered in Norwalk, CT. | Health Technology |
Naurex, Inc.
Naurex, Inc. Pharmaceuticals: MajorHealth Technology Naurex, Inc. operates as a clinical-stage company, which develops therapies. The firm offers therapies for depression and other disorders in the central nervous system based on a mechanism of action for modulating the NMDA receptor (NMDAR). It offers a line of chemical drug classes, such as glycine-site functional partial agonists, which modulate the receptor in a different way than existing NMDAR agents. The firm provides GLYX-13, an NRX-1050 small molecule series and additional compounds for treatment-resistant depression. The company was founded by Joseph R. Moskal in 2006 and is headquartered in Evanston, IL. | Health Technology |
AlgoRx Pharmaceuticals, Inc.
 AlgoRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AlgoRx Pharmaceuticals, Inc. was a pharmaceutical company. The company developed and commercialized drugs for pain management. The company was founded in 2001 and was hedquartered in Secaucus, NJ. | Health Technology |
Embark Healthcare
Embark Healthcare Investment ManagersFinance Embark Healthcare (Embark Healthcare) is a ventures capital firm founded in 2001 by David M Geliebter. The firm is headquartered in New York. | Finance |
